Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Overview of essential tremor

Authors Zesiewicz T, Chari A, Jahan I, Miller AM, Sullivan KL

Published 7 July 2010 Volume 2010:6(1) Pages 401—408

DOI https://doi.org/10.2147/NDT.S4795

Review by Single-blind

Peer reviewer comments 3


Theresa A Zesiewicz, Abinaya Chari, Israt Jahan, Amber M Miller, Kelly L Sullivan

Department of Neurology, Parkinson Research Foundation, James A. Haley Veterans Administration Hospital,
University of South Florida, Tampa, FL, USA

Abstract: Essential tremor (ET) is one of the most common movement disorders in the world. Despite this, only one medication (propranolol) is approved by the Food and Drug Administration (FDA) to treat it. Fortunately, recent studies have identified some additional medications as treatment of ET. Surgical procedures, such as deep brain stimulation of the ventral intermediate nucleus of the thalamus, offer treatment for refractory tremor. The epidemiology, pathogenesis, and medical and surgical treatment of ET will be discussed in this paper.

Keywords: Essential tremor, diagnosis, treatment, pathogenesis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]